Prevalence of cardiovascular events in diabetic patients taking sulphonylureas: need for assessment
Rohra, D.Kumar.; Maheshwary, A.Raysee.; Gauba, S.Shamlal.
Jpma. Journal of the Pakistan Medical Association 57(3): 163
2007
ISSN/ISBN: 0030-9982 PMID: 17432030 Document Number: 607446
Document emailed within 1 workday
Related Documents
Millard, P.S. 2003: Do irbesartan and amlodipine reduce cardiovascular events in diabetic patients? Journal of Family Practice 52(8): 593-594Fellah, H.; Feki, M.; Feki, H.; Souissi, M.; Kaabachi, N.; Abdallah, T.B.; Massy, Z.A.; Maiz, H.B.; Lacour, B.; Mebazaa, A. 2004: Classical and "Non-classical" Cardiovascular Risk Factors in Tunisian Patients with End Stage Renal Disease: Prevalence and Association with Cardiovascular Events Clinical Laboratory 50(7-8): 447-453
Penesova, A.; Cizmarova, E.; Koska, J. 2006: Early assessment of metabolic situation in young patients with hypertension may prevent subsequent adverse cardiovascular events Bratislavske Lekarske Listy 107(1-2): 41-42
Chen, Y.; Wang, J.; An, Y.; Gong, Q.; He, Y.; Zhang, B.; Li, H.; Shuai, Y.; Tang, X.; Jiang, Y.; Hong, J.; Yang, W.; Hu, Y.; Li, G. 2015: Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study Zhonghua Nei Ke Za Zhi 54(1): 13-17
Protopopova, D.; Masopust, J.; Maly, R.; Valis, M.; Bazant, J. 2012: The prevalence of cardiometabolic risk factors and the ten-year risk of fatal cardiovascular events in patients with schizophrenia and related psychotic disorders Psychiatria Danubina 24(3): 307-313
2005: To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too MMWFortschrittederMedizin 147(33-34): 51
Enck, P.; Rathmann, W.; Spiekermann, M.; Czerner, D.; Tschöpe, D.; Ziegler, D.; Strohmeyer, G.; Gries, F.A. 1994: Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects Zeitschrift für Gastroenterologie 32(11): 637-641
2014: Ivabradine and patients with coronary artery disease: more cardiovascular events Prescrire international 23(155): 295
Matsuto, T.; Inano, K.; Miida, T.; Okada, M. 1998: Assessment of diabetic cardiovascular autonomic neuropathy by heart rate variability and pulse wave velocity Rinsho Byori. Japanese Journal of Clinical Pathology 46(10): 1037-1042
Guo, Y.F. 2019: Effects of aspirin on primary prevention of cardiovascular events in patients with hypertension Zhonghua Nei Ke Za Zhi 58(4): 249-251
Yamaguchi, S.; Gohda, T.; Gotoh, H.; Omote, K.; Furukawa, M.; Ishikawa, Y.; Tomino, Y. 2013: Factors associated with cardiovascular death and events in patients with end stage renal disease Nihon Jinzo Gakkai Shi 55(2): 159-166
Nossent, H. 2000: Risk of cardiovascular events and effect on mortality in patients with rheumatoid arthritis Journal of Rheumatology 27(9): 2282-2283
Hartley, H. 1996: The reduction of cardiovascular events after a myocardial infarct in patients with normal cholesterol levels Revista Clinica Espanola 196(4 Monografico): 43-46
Klomp, C.M.C.; ten Cate, H.; Stehouwer, C.D.A.; Schaper, N.C. 2009: Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events Nederlands Tijdschrift Voor Geneeskunde 153: A109
Bissonnette, R.; Kerdel, F.; Naldi, L.; Papp, K.; Galindo, C.; Langholff, W.; Tang, K.L.; Szapary, P.; Fakharzadeh, S.; Srivastava, B.; Goyal, K.; Gottlieb, A.B. 2017: Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis Journal of Drugs in Dermatology: Jdd 16(10): 1002-1013
Suppadungsuk, S.; Yamwong, S.; Sungkanuparph, S. 2013: Risk of cardiovascular events predicted by the Rama-EGAT score among HIV-infected patients in Thailand Southeast Asian Journal of Tropical Medicine and Public Health 44(5): 818-824
Gollapudi, A.K. 2008: Do lipid-lowering agents provide a greater reduction in cardiovascular events among patients with diabetes? Annals of Internal Medicine 149(11): 841; Author Reply 841-2
Zhao, Y.; Wang, W.Y.; Tian, J.; Zhang, X.; Yang, M.; Chen, J.; Mu, M.; Tang, Y.D. 2019: Impact of low T3 syndrome on adverse cardiovascular events in adult patients with acute viral myocarditis Zhonghua Xin Xue Guan Bing Za Zhi 47(6): 447-451
Ebell, M.H. 2017: In Patients with Vascular Disease, Treating Sleep Apnea Does Not Reduce the Risk of Cardiovascular Events American Family Physician 95(2): 123-123
Jungers, P.; Nguyen Khoa, T.; Massy, Z.A.; Man, N.K. 1998: Incidence of atherosclerotic cardiovascular events in patients with chronic uremia: epidemiologic studies in Ile-de-France Nephrologie 19(8): 489-494